Ask AI

When Good Isn't Good Enough: Balancing the Augmentation Equation in MDD

Advances in adjunctive pharmacotherapy are expanding treatment considerations for patients with major depressive disorder (MDD) who experience incomplete response to antidepressants. Through this expert-led content, examine current evidence for approved adjunctive atypical antipsychotics and other augmentation strategies, including differences in efficacy, safety, and tolerability, and explore approaches to matching treatment mechanisms and dosing strategies with residual symptoms and individual patient needs.

Share

Program Content

Events

Activities

Augmentation in MDD
When Good Isn’t Good Enough: Balancing the Augmentation Equation in MDD
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.